4//SEC Filing
Denali Capital Global Investments LLC 4
Accession 0001213900-24-078775
CIK 0001913577other
Filed
Sep 15, 8:00 PM ET
Accepted
Sep 16, 10:05 AM ET
Size
7.2 KB
Accession
0001213900-24-078775
Insider Transaction Report
Form 4
Transactions
- Sale
Class B Ordinary Shares
2024-08-30−500,000→ 1,432,500 total→ Class B Ordinary Shares (500,000 underlying)
Footnotes (2)
- [F1]The Class B ordinary shares will automatically convert into Class A Ordinary Shares, par value $0.0001 per share ("Class A Ordinary Shares"), of the Issuer concurrently with or immediately following the consummation of the Issuer's initial business combination, or earlier at the option of the holder, on a one-for-one basis, subject to adjustment.
- [F2]On August 30, 2024, (i) the Issuer, Denali Merger Sub Inc., and Semnur Pharmaceuticals, Inc. ("Semnur"), a Delaware corporation and wholly owned subsidiary of Scilex Holding Company ("Scilex") entered into an agreement and plan of merger and (ii) the Reporting Person and Scilex entered into a Sponsor Interest Purchase Agreement (the "SIPA"). Pursuant to the SIPA, Scilex agreed to purchase 500,000 Class B ordinary shares of the Issuer held by the Reporting Person for aggregate consideration of (i) $2,000,000 (the "Cash Consideration") and (ii) 300,000 shares of common stock, par value $0.0001 per share, of Scilex (the "Scilex Shares"). Pursuant to the SIPA, Scilex paid the Cash Consideration to the Reporting Person on August 30, 2024 and has agreed to issue the Scilex Shares to the Reporting Person contingent upon and following the occurrence of the effective time of the Merger.
Documents
Issuer
Denali Capital Acquisition Corp.
CIK 0001913577
Entity typeother
IncorporatedCayman Islands
Related Parties
1- filerCIK 0001920832
Filing Metadata
- Form type
- 4
- Filed
- Sep 15, 8:00 PM ET
- Accepted
- Sep 16, 10:05 AM ET
- Size
- 7.2 KB